Latest News

Severe Psoriasis Associated With Higher Risk of Heart Disease
Severe Psoriasis Associated With Higher Risk of Heart Disease

September 26th 2023

Researchers explored the relationship between psoriasis severity and its link to coronary microvascular dysfunction in the largest such study to date.

FDA Delays UCB’s Bimekizumab Approval
FDA Delays UCB’s Bimekizumab Approval

September 20th 2023

Accurately Recognizing and Diagnosing Psoriasis in Patients With Skin of Color
Accurately Recognizing and Diagnosing Psoriasis in Patients With Skin of Color

September 20th 2023

Dermoscopy Aids in Diagnosing Psoriasis Vulgaris and Nail Psoriasis
Dermoscopy Aids in Diagnosing Psoriasis Vulgaris and Nail Psoriasis

September 19th 2023

Treating All Skin Tones
Treating All Skin Tones

September 19th 2023

Latest CME Events & Activities

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Clinical Consultations: Individualizing Management of Uveitic Macular Edema - Clinical Updates in Treatment Options

View More

Expert Illustrations and Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

Register Now!

EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care

Register Now!

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Addressing Challenges in the Management of HS in Special Populations

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

View More

© 2023 MJH Life Sciences

All rights reserved.